Key result
Pulse contour cardiac output-guided therapy stabilizes pheochromocytoma-induced acute heart failure.
Why the study?
Pheochromocytoma patients rarely present with acute heart failure or cardiogenic shock, and management guidance is limited.
Case Report (n=1)
Pulse contour cardiac output data can guide diagnosis and treatment in patients with pheochromocytoma presenting as Takotsubo-pattern cardiomyopathy and acute heart failure.
Hypothesis-generating for pulse contour-guided care in pheochromocytoma heart failure; prospective validation required before practice change.
BACKGROUND: Pheochromocytoma is an endocrine tumor that causes hypertension, facial pallor, and headache. Pheochromocytoma patients rarely present with acute heart failure or cardiogenic shock. METHOD: We discuss the case of a female patient with Takotsubo-pattern cardiomyopathy who presented with acute heart failure caused by pheochromocytoma. RESULT: Treatment was adjusted based on the data of the pulse contour cardiac output system. After intensive hydration and medication for heart failure, the condition of the patient stabilized. CONCLUSION: Before confirming the diagnosis, pulse contour cardiac output data could provide a direction for diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Chiang et al. (2016) conducted a case report in Pheochromocytoma presenting with Takotsubo-pattern cardiomyopathy and acute heart failure (n=1). Treatment guided by pulse contour cardiac output system data, intensive hydration, and heart failure medication was evaluated on Patient stabilization. Treatment guided by pulse contour cardiac output data, along with intensive hydration and heart failure medication, stabilized a female patient with pheochromocytoma-induced acute heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: